- (-%)
Source:
Enzon Pharmaceuticals, Inc. is positioned as a public company acquisition vehicle, where we can become an acquisition platform and more fully utilize our net operating loss carryforwards (“NOLs”) and enhance stockholder value.
Country | United States |
Headquarters | cranford, new jersey |
Phone Number | 732-980-4500 |
Industry | manufacturing |
CEO | Richard L. Feinstein |
Website | www.enzon.com |